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The effects of the quaternary agent meproadifen on ACh-activated channel currents were studied on myo- 
balls cultured from hind limb muscles of neonatal rats. Meproadifen (0.02-0.1 PM) combined with ACh 
(0.1-0.3 PM) in the patch pipette caused an increase, followed by a decrease, in the frequency of channel 
openings. At concentrations greater than 0.2 PM the initial phase was not detected and a rapid and marked 
reduction in the opening frequency was observed. Meproadifen (up to 2.5 PM) produced no change in the 
duration or conductance of the open state of ACh-activated channels. In addition, this agent induced the 
appearance of events with a marked increase in the ‘noise’ during the opening phase. The lack of effect 
under inside-out patch conditions suggested that meproadifen binds to a site located at the external portion 
of the nicotinic macromolecule and has no access to it through the cell membrane. This study indicated 
that non-competitive antagonists uch as meproadifen can facilitate receptor activation and desensitization. 
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1. INTRODUCTION 
Previous studies on the acetylcholine receptor- 
ionic channel complex (AChR) of the frog neuro- 
muscular junction and the Torpedo electric organ 
membranes have shown that the quaternary agent 
meproadifen (fig.1) increases the affinity of the 
agonist for its binding site and enhances desensiti- 
zation [ 1,2]. The electrophysiological assertions 
were based on a series of observations including: (i) 
voltage- and time-dependent depression of the end- 
plate current (EPC) peak amplitude as revealed by 
nonlinearity and hysteresis in the current-voltage 
relationship; (ii) rundown of the EPC amplitude 
with repetitive nerve stimulation, and (iii) reduc- 
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tion of junctional and extrajunctional response to 
microiontophoretic application of ACh. More- 
over, persistence of these effects in the absence of 
any significant change in either the time constant 
of the EPC decay phase (TEPC) or the single chan- 
nel conductance and mean lifetime determined 
from noise analysis indicated that meproadifen 
exerts its affects on activation of ionic channels 
without affecting the conducting species of the 
AChR complex. 
Our objectives are to observe the effects of 
meproadifen on properties of single currents; to 
C2H5 
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Fig. 1. Chemical structure of meproadifen. 
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characterize at the level of the elementary currents 
enhancement of desensitization induced by an in- 
crease in agonist affinity for its receptor site; to 
estimate the location of the meproadifen binding 
site on the AChR complex and to determine the 
access route to it by a selective application of the 
drug to either side of the cell membrane under dif- 
ferent patch-clamp conditions. An abstract of this 
work has been presented 131. 
2, MATERIALS AND METHODS 
The single channel current recordings were per- 
formed at 10°C on myoballs cultured from hind 
limb muscles of I-Zday-old rat pups using the im- 
proved patch-clamp technique 141, Myoballs, which 
formed spontaneously (i.e., without addition of 
colchicine) in I-Zweek-old cultures, were used. 
Upon removai of cultures from the incubator, the 
nutrient medium was replaced with Hanks’ solu- 
tion [composition (mM): NaCl, 137; KCl, 5.4; 
NaHC03,4.2; CaCl2, 1.3; MgS04,0.81; KHzP04, 
0.44; NazHP04, 0.34; D-glucose, 5.5; Hepes, 10; 
pH7.21 to which was added tetrodotoxin @TX, 
0,3/1M) to abolish the cell contraction. An LM- 
EPC-5-Patch System (List Electronic) was used to 
record single channel currents which were filtered 
to 3 KHz (second order, Bessel low pass) and 
stored on FM magnetic tape for computer analysis. 
The data were sent to a PDP 1 l/40 minicomputer 
through a fourth-order Butterworth (low-pass) 
filter (I-3 kHz), to improve the signal-ta-noise 
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Fig.2. Total amplitude histograms of channel currents recorded at various time intervals (pipette contained a mixture 
of 0.3pM ACh and 0.5pM meproad~fen~, The abscissa shows the current amplitude in PA. The largest peak, centered 
around OmV, represents the noise level of the nonconducting state of AChR compiex. The position of the second 
largest peak on the abscissa (2.7 pAf indicates the amplitude of the single channel current. The peak at amplitude of 
4.2 pA corresponds to ACh-activated channels with higher conductance frequently observed in rat myoballs under con- 
trol conditions [8]. 
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ratio and digitized at 2-10KHz. An automated 
analysis provided amplitude and open time histo- 
grams from which the conductance and mean open 
time of ACh-activated channels were estimated. 
Details of the patch-clamp experiments and the cell 
culture procedure have been described [5]. 
3. RESULTS 
Interaction of meproadifen and acetylcholine at 
the nicotinic receptor-ion channel complex of 
neonatal rat myoballs: In our recordings, a high 
percentage of ACh-channel openings disclosed a 
conductance value (obtained from the slope of the 
current-voltage plot) of 20 pS. Events with conduc- 
tance of 33 and IOpS were also observed [6]. 
Application of meproadifen (0.02-2.5pM) to- 
gether with ACh (0.3pM) to the external surface of 
Fig.3. Open time histograms of channel currents re- Fig.4. Concentration-dependent effect of meproadifen 
corded with the patch micropipettes containing ACh on the frequency of channel openings. Gigaohm seals 
(0.3~M) alone and together with meproadifen (OSrM). were established with the pipette containing ACh 0.3/M 
Holding potential -140mV. and meproadifen at different concentrations. 
the cell membrane via the patch micropipettes did 
not alter the properties of ACh-activated single 
channel currents, i e., both channel conductance 
and the duration of the open state were similar to 
control values obtained with ACh alone inside the 
micropipette (fig.2,3). The open channel histo- 
grams showed an excessive number of short events 
which contributed to a departure from a single 
exponential distribution similar to that seen under 
control conditions. However, meproadifen caused 
a marked effect on the frequency of ACh-activated 
channel openings (fig.4, table 1). Meproadifen 
(>0.2pM) produced an immediate and a concen- 
tration-dependent decrease of the opening fre- 
quency, detectable at the first minute after the 
establishment of the gigaohm seal, such that at 
above 2.5,~M no channel activity could be re- 
corded. An initial increase in the frequency of 
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Table 1 
Effect of meproadifen on frequency of ACh-activated channel opening? 
Condition of drug application Meproadifen 
concentration 
(PM) 
Frequency of channel openings (min-1) 
Control 1 min 15 min 
I. 
II. 
Bathing superfusion 
A. Cell-attached patch 10pM 293 - 292 
B. Inside-out patch 5PM 197 - 193 
Micropipette: 0.3 ,uM ACh + meproadifen 0.2pM _ 246 58 
0.5pM _ 153 36 
l.OuM - 115 10 
a The values refer to the frequency (number of events per min) determined under control condition and 15 min after 
starting drug superfusion in IA and B and 1 and 15 min after establishment of the gigaohm seals in II. In IA and B 
the concentration of ACh in the micropipette was 0.3pM 
ACh O.l@l + MEPROADIFEN O.OWM 
Fig/S. Samples of ACh-activated channel currents recorded from cell-attached patches in the presence of meproadifen. 1 
Note in addition to the unchanged channel currents, the presence of many events with enlarged baseline and flickers 
during the open phase. 
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Fig.6. (A) Baseline broadening during the open state of 
ACh-activated channel openings induced in the presence 
of meproadifen. Patch micropipettes contained (1) ACh, 
0.2pM; (2) ACh, 0.2pM; bupivacaine, 20pM; (3) ACh, 
O.lpM; meproadifen, O.OSpM. Holding potential 
-lOOmV. In contrast to meproadifen, notice the short 
events with normai thickness of the baseline in the 
presence of bupivacaine (2). (B) Amplitude histogram of 
the events shown in (3). Bandwidth 3 kHz. 
channel openings, followed by a decrease, was 
observed at below 0.1 yM. Grouping of events 
with multiple simultaneous openings characterizing 
the initial phase gradually disappeared as the effect 
of the drug proceeded and bursts between long silent 
intervals were seen. We also observed the appear- 
ance of events with low conductance (- 10 pS) after 
3 min exposure to 0.5pM meproadifen together 
with 0.3pM ACh (fig.2,4). These events, which 
became clearly noticeable during the following 
10 min, gradually disappeared after 15 min ex- 
posure to the drug. Moreover, in the presence of 
meproadifen (0.05&M), some channel openings 
activated by ACh (0.2pM) exhibited a marked 
thickening of the base line during the opening 
phase which appears to be composed of high fre- 
quency events (fig.5). Since the distribution of 
amplitude points is skewed to the left (fig.6B), it is 
likely that the apparent increase in current fluctua- 
tions is due to the presence of inadequately de- 
tected short closures. At high concentration of 
meproadifen (>0,2pM) these events were rarely 
observed. Fig.6A shows this phenomenon in more 
detail and also provides a comparison of these 
events with single channel currents activated by 
ACh alone and by ACh in the presence of a typical 
open channel blocker, bupivacaine. Neither ACh 
alone nor in combination with bupiva~ine ex- 
hibited the perturbations of the opening state 
observed with meproadifen. 
Superfusion of bathing solution containing a 
high concentration of meproadifen (%lO/cM) 
alone to the external face in cell-attached patch or 
to the c~opl~mic side of the cell membrane in 
inside-out patch produced no effect on the ampli- 
tude and duration of channel currents activated by 
ACh (fig.7), as in the case of application via the 
pipette. However, the changes in frequency of 
events observed with ACh plus meproadifen in the 
pipette and the widening of the baseline during the 
open channel were not present with any of the 
other methods of application (table 1). 
4. DISCUSSJON 
This study has revealed actions of meproa~fen 
on ACh-activated single channel currents. In a 
previous study, it was shown that the agent en- 
hances the agonist-mediated conversion of the 
nicotinic receptor from a state of low affinity to 
one of high affinity which is associated with a slow 
decline of the permeability response of the muscle 
membrane [1,2]. In agreement with the voltage- 
clamp data which disclosed no change in the decay 
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Fig.7. Application of meproadifen via the bath in inside-out patch condition after the establishment of the gigaohm 
seal. Total amplitude and open time histograms correspond to single channel currents activated by 0.3pM ACh before 
(left) and after 15 min exposure to 5pM meproadifen. The peaks located at 2.25 and 4.5 pA on the abscissa represent 
respectively the current amplitude of a single channel opening and two channels opening simultaneously. 
time constant of the endpoint currents (EPC), 
single channel current recordings revealed that 
meproadifen did not significantly change the single 
channel open time. However, ACh-activated single 
channels recorded in the presence of very low 
concentrations of meproadifen (0.02-O.OlpM) 
produced an initial increase in the frequency of 
channel-opening events which was followed by a 
significant decrease in channel activation. The ini- 
tial increase in channel opening frequency was not 
detected at concentrations of the agent greater 
than 0.2pM, and only the latter phase of the drug 
action, i.e., a rapid and marked depression of 
channel opening frequency was observed (fig.4, 
table 1). Enhanced grouping of channel openings 
followed by long quiescent periods may reflect en- 
hancement of the receptor desensitization induced 
272 
by meproadifen [7]. On the other hand, at the 
macroscopic level, this phenomenon might be 
evidenced by a use-dependent depression, or run- 
down, of the EPC amplitude and the marked de- 
pression of the junctional and extrajunctional 
sensitivity to microiontophoresis of ACh observed 
in the presence of 5-20,uM meproadifen [2]. More- 
over, at suitable concentrations this agent induced 
appearance of events with an increased number of 
very short closures and broadening of the baseline 
during the open state. Although further studies are 
required to evaluate this alteration of the baseline 
during channel opening, it is tempting to speculate 
whether these altered events are correlated to the 
high affinity species of the nicotinic AChR com- 
plex. A similar effect, but to a lesser extent, was 
exhibited by other agents such as pyridostigmine 
Volume 174, number 2 FEBS LETTERS September 1984 
which aside from anticholinesterasic activity also 
increased the affinity of the agonist for its binding 
site, enhanced receptor desensitization and be- 
haved as a weak agonist at the AChR complex [5]. 
This pattern was not shared by agents such as bupi- 
vacaine (see fig.6) which acted essentially as an 
open channel blocker and had no effect on agonist- 
induced receptor desensitization [6,8]. The absence 
of any alteration of the properties (amplitude and 
channel lifetime) of the single channel currents 
activated by ACh, suggested that meproadifen did 
not affect the conducting species of AChR com- 
plex. As proposed for phenothiazine neuroleptics 
[9], which cause an increase in the affinity of ACh 
for its binding site and induce desensitization, 
meproadifen at suitable concentrations may inter- 
act with the resting, nonconducting species of the 
AChR complex to stabilize it or shift the equi- 
librium between the concentrations of the closed, 
activated and open AChR in favor of a desensi- 
tized conformation. However, meproadifen and 
phenothiazines may bind to a different class of 
sites, proposed for drugs which stabilize the high 
affinity species of the AChR complex, which in- 
cludes one which is sensitive and one insensitive to 
voltage [ 10-121. In contrast to the phenothiazines, 
the enhancement of desensitization by mepro- 
adifen may be due to its preferential binding to a 
voltage-sensitive site at the AChR complex. In addi- 
tion, the appearance of low-conductance events 
(fig.2) in the presence of this agent could be related 
to a weak agonistic property similar to that of pyri- 
dostigmine [5]. However, meproadifen at concen- 
tration range of 0.1-l ,uM did not show such 
effect. On the other hand, since the low-conduc- 
tance events can be activated, albeit infrequently, 
by ACh itself [6], it is more probable that the fre- 
quency of these events is increased as a consequence 
of .facilitation of receptor activation by mepro- 
adifen. 
One important aspect of the interactions of 
meproadifen with the AChR complex which can be 
determined using patch-clamp technique is the 
location of the binding site(s) responsible for its 
effects. The selective application of meproadifen 
to the intracellular side of the cell membrane under 
inside-out patch condition, in contrast to applica- 
tion of the drug together with the agonist to the 
extracellular face of the membrane, did not affect 
the kinetics of the ACh channel activation. Simi- 
larly, when meproadifen was superfused in the 
bathing medium outside the pipette in cell-attached 
patch condition no significant change was ob- 
served in the properties of the single channel cur- 
rents. Assuming that meproadifen is not able to 
pass through the space between the micropipette 
and the cell surface after the establishment of the 
g&aohm seal [4,5], these results suggest hat the 
drug also does not diffuse through the cell mem- 
brane. Similar findings were reported for other 
quaternary agents such as bupivacaine methiodide 
[6] and QX-222 [13]; however, the anticholinester- 
asic agent pyridostigmine has a definitive effect on 
the ACh channel activation under any patch-clamp 
conditions [5]. Additionally, the absence of any 
effect when this agent was applied to the bathing 
medium under inside-out condition, suggests that 
most likely there is no site for meproadifen inter- 
actions at the internal segments of the AChR 
macromolecule. The availability of more selective 
agents uch as bupivacaine, which exhibits a power- 
ful blockade of the open conformation of the ACh 
channels, and drugs such as meproadifen and 
phenothiazines, which have the capability of 
accelerating the desensitization of the nicotinic 
receptor, has allowed a distinction between the dif- 
ferent sites at the ionic channel of AChR complex 
which are known to bind a great variety of non- 
competitive antagonists [141. 
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